Adjuvant Capital

New York, New York
Founded:2012
Firm Location:New York, New York • San Francisco, California • Amsterdam, Netherlands • Germany • Melbourne, Australia
Adjuvant Capital Team
Photo of Joshua Adeoye, Associate at Adjuvant Capital
Joshua Adeoye
Adjuvant Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in BioTech, Investors in Consumer Health, Investors in Diagnostics, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Kabeer Aziz, Principal at Adjuvant Capital
Kabeer Aziz
Adjuvant Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech, Investors in Consumer Health, Investors in Diagnostics, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Michael Chang, Venture Partner at Adjuvant Capital
Michael Chang
Adjuvant Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech, Investors in Consumer Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists)
Photo of Lilly deSouza Burr, Principal at Adjuvant Capital
Lilly deSouza Burr
Adjuvant Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech, Investors in Consumer Health, Investors in Diagnostics, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Philippe Dro, Partner at Adjuvant Capital
Philippe Dro
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Investors in BioTech, Investors in Consumer Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Therapeutics
Photo of Curt LaBelle, Venture Partner at Adjuvant Capital
Curt LaBelle
Adjuvant Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Investors in BioTech, Investors in Consumer Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Charlie Petty, Venture Partner at Adjuvant Capital
Charlie Petty
Adjuvant Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $300.0M
Investors in New York (NY)
Investors in BioTech, Investors in Consumer Health, Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Glenn Rockman, Managing Partner at Adjuvant Capital
Glenn Rockman
Adjuvant Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech, Investors in Consumer Health, Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Impact, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Dimple Sahni, Investor at Adjuvant Capital
Dimple Sahni
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech, Investors in FinTech, Investors in Impact
Photo of Mark Sullivan, Venture Partner at Adjuvant Capital
Mark Sullivan
Adjuvant Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Melbourne (Australia)
Investors in BioTech, Investors in Consumer Health, Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
Photo of Jenny Yip, Managing Partner at Adjuvant Capital
Jenny Yip
Adjuvant Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in BioTech, Investors in Consumer Health, Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)